Role of Lipid Polymorphism in Pulmonary Surfactant
- 19 July 1996
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 273 (5273) , 330-332
- https://doi.org/10.1126/science.273.5273.330
Abstract
The development of artificial surfactants for the treatment of respiratory distress syndrome (RDS) requires lipid systems that can spread rapidly from solution to the air-water interface. Because hydration-repulsion forces stabilize liposomal bilayers and oppose spreading, liposome systems that undergo geometric rearrangement from the bilayer (lamellar) phase to the hexagonal II (H II ) phase could hasten lipid transfer to the air-water interface through unstable transition intermediates. A liposome system containing dipalmitoylphosphatidylcholine was designed; the system is stable at 23°C but undergoes transformation to the H II phase as the temperature increases to 37°C. The spreading of lipid from this system to the air-water interface was rapid at 37°C but slow at 23°C. When tested in vivo in a neonatal rabbit model, such systems elicited an onset of action equal to that of native human surfactant. These findings suggest that lipid polymorphic phase behavior may have a crucial role in the effective functioning of pulmonary surfactant.Keywords
This publication has 27 references indexed in Scilit:
- Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactantThe Journal of Pediatrics, 1995
- One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placeboThe Journal of Pediatrics, 1995
- One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placeboThe Journal of Pediatrics, 1995
- Changes in oxygenation and heart rate after administration of artificial surfactant (ALEC) to preterm infants.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- Prognostic value of the immediate response to surfactant.Archives of Disease in Childhood: Fetal & Neonatal, 1994
- Early changes in lung function and response to surfactant replacement therapyEuropean Journal of Pediatrics, 1994
- Surface analysis of lipid layers at air/water interfacesLangmuir, 1990
- Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestationEarly Human Development, 1988
- Head group modulation of membrane fluidity in sonicated phospholipid dispersionsBiochemistry, 1974
- The surface properties of pure phospholipids in relation to those of lung extractsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968